KORU Medical Systems, Inc. Receives FDA 510(k) Clearance For FREEDOM60 Infusion System With Hizentra 50 ML Prefilled Syringes
Portfolio Pulse from Benzinga Newsdesk
KORU Medical Systems, Inc. (NASDAQ:KRMD) has received FDA clearance for the use of the FREEDOM60 Infusion System with Hizentra 50 mL prefilled syringes. This makes it the first and only FDA-cleared infusion system for use with prefilled syringes. The system is expected to significantly improve the ease of use for patients self-administering subcutaneous immunoglobulin therapy at home.
November 07, 2023 | 10:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
KORU Medical's FDA clearance for the FREEDOM60 Infusion System with Hizentra prefilled syringes could potentially boost the company's market position and revenues.
The FDA clearance for KORU Medical's FREEDOM60 Infusion System with Hizentra prefilled syringes is a significant milestone for the company. This could potentially increase the company's market share and revenues as it is the first and only FDA-cleared infusion system for use with prefilled syringes. This system is expected to significantly improve the ease of use for patients self-administering subcutaneous immunoglobulin therapy at home, which could lead to increased demand for the product.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100